{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:40:46Z","timestamp":1790430046100,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WE4896\/3-1"],"award-info":[{"award-number":["WE4896\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WE4896\/4-1"],"award-info":[{"award-number":["WE4896\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.yebeh.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T10:12:34Z","timestamp":1533031954000},"page":"90-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"special_numbering":"C","title":["The glucose transporter type 1 (Glut1) syndromes"],"prefix":"10.1016","volume":"91","author":[{"given":"Henner","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne G.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2018.06.010_bb0005","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","article-title":"Glucose transporters in the 21st century","volume":"298","author":"Thorens","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P","article-title":"Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome","volume":"16","author":"Wang","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0015","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1172\/JCI34438","article-title":"GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak","volume":"118","author":"Weber","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.21724","article-title":"Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1","volume":"66","author":"Suls","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0025","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1074\/jbc.M310786200","article-title":"Analysis of transmembrane segment 8 of the GLUT1 glucose transporter by cysteine-scanning mutagenesis and substituted cysteine accessibility","volume":"279","author":"Mueckler","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2337\/diab.37.5.657","article-title":"Characterization and expression of human HepG2\/erythrocyte glucose-transporter gene","volume":"37","author":"Fukumoto","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199109053251006","article-title":"Defective glucose transport across the blood\u2013brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay","volume":"325","author":"De Vivo","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng0298-188","article-title":"GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood\u2013brain barrier hexose carrier","volume":"18","author":"Seidner","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s100720100070","article-title":"Paroxysmal dystonia with thalamic lesion in multiple sclerosis","volume":"22","author":"Zenzola","year":"2001","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0055","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/humu.22126","article-title":"PRRT2 mutations are the major cause of benign familial infantile seizures","volume":"33","author":"Schubert","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0060","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.24580","article-title":"Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation","volume":"79","author":"Gardella","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0065","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/hmg\/ddh330","article-title":"The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway","volume":"13","author":"Lee","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0070","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archneur.61.7.1025","article-title":"Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis","volume":"61","author":"Rainier","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0075","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/hmg\/ddr125","article-title":"Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability","volume":"20","author":"Shen","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng1585","article-title":"Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder","volume":"37","author":"Du","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0085","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1111\/epi.12007","article-title":"Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency","volume":"53","author":"Arsov","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eplepsyres.2012.11.004","article-title":"The role of SLC2A1 in early onset and childhood absence epilepsies","volume":"105","author":"Muhle","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0095","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1111\/epi.13222","article-title":"The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome","volume":"56","author":"Larsen","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1212\/WNL.0b013e318247ff54","article-title":"GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy","volume":"78","author":"Striano","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0105","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archneurol.2011.102","article-title":"Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy","volume":"68","author":"Mullen","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.0b013e31822e0479","article-title":"Paroxysmal choreoathetosis\/spasticity (DYT9) is caused by a GLUT1 defect","volume":"77","author":"Weber","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/geno.1996.0013","article-title":"A gene for autosomal dominant paroxysmal choreoathetosis\/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197","volume":"31","author":"Auburger","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0120","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00415-014-7433-5","article-title":"Focal epilepsy in glucose transporter type 1 (Glut1) defects: case reports and a review of literature","volume":"261","author":"Wolking","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.20331","article-title":"Glut1 deficiency syndrome: clinical, genetic, and therapeutic aspects","volume":"57","author":"Wang","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0130","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/dmcn.13163","article-title":"Evaluation of non-coding variation in GLUT1 deficiency","volume":"58","author":"Liu","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pediatrneurol.2007.03.009","article-title":"GLUT1 deficiency with delayed myelination responding to ketogenic diet","volume":"37","author":"Klepper","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.24970","article-title":"A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome","volume":"82","author":"Gras","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.braindev.2009.02.008","article-title":"The expanding phenotype of GLUT1-deficiency syndrome","volume":"31","author":"Brockmann","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.10311","article-title":"Imaging the metabolic footprint of Glut1 deficiency on the brain","volume":"52","author":"Pascual","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0155","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awn113","article-title":"Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1","volume":"131","author":"Suls","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00431-002-0939-3","article-title":"Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain\u2014a review","volume":"161","author":"Klepper","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mds.20660","article-title":"Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet","volume":"21","author":"Friedman","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/practneurol-2015-001194","article-title":"Glut1 deficiency syndrome: absence epilepsy and La Soupe du Jour","volume":"16","author":"Thouin","year":"2016","journal-title":"Pract Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1528-1157.2003.05302.x","article-title":"Seizure characterization and electroencephalographic features in Glut1 deficiency syndrome","volume":"44","author":"Leary","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0180","first-page":"307","article-title":"The effect on ketonemia on the course of epilepsy","volume":"2","author":"Wilder","year":"1921","journal-title":"Mayo Clin Bull"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2007.02.008","article-title":"The neuropharmacology of the ketogenic diet","volume":"36","author":"Hartman","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","article-title":"The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial","volume":"7","author":"Neal","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.plefa.2003.07.004","article-title":"Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome","volume":"70","author":"Klepper","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.yebeh.2018.06.010_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3013","article-title":"Gene therapy for Glut1-deficient mouse using an adeno-associated virus vector with the human intrinsic GLUT1 promoter","volume":"20","author":"Nakamura","year":"2018","journal-title":"J Gene Med"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018303482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018303482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:25:08Z","timestamp":1761503108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505018303482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":40,"alternative-id":["S1525505018303482"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.06.010","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The glucose transporter type 1 (Glut1) syndromes","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}